We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Central Garden & Pet's (CENT) DoMyOwn Buyout to Boost Sales
Read MoreHide Full Article
As online activities have picked up amid the coronavirus crisis, Central Garden & Pet Company (CENT - Free Report) is committed toward accelerating its digital efforts. Encouragingly, the company recently bought DoMyOwn.com (DoMyOwn), which is a fast-growing online retailer of professional-grade control products across the United States. The deal adds best-in-class e-commerce fulfillment platform and digital capabilities to the company’s portfolio as well as fortifies Central Garden & Pet’s position in the control product space. We note that the transaction was completed on Dec 18, 2020, and terms of the deal including purchase price have been kept under wraps.
Founded in Norcross, GA, in 2004, DoMyOwn used to initially focus on selling professional-grade control products online. In 2012, it added turf and ornamental products. Later in 2017, the online company had enhanced its geographical reach with warehouse additions in Utah and expanded into pet and equine products. Its digitally-driven management group and nearly 70 employees helped it become the leading online and wholesale supplier of professional-grade control products for do-it-yourself customers.
Markedly, the latest acquisition fits pretty well with Central Garden & Pet’s ‘Central to Home’ initiative. This strategy is devoted toward catering to consumer needs, reinforcing partnerships, building scale in core categories and adding digital capabilities. With the help of this acquisition, Central Garden & Pet will be able to tap and cater to the rising e-commerce demand of consumers and the retail customers’ omni-channel platforms.
Acquisition Strategy Drives Sales
We note that acquisitions form an important part of Central Garden & Pet’s strategy. The company has expanded its business via more than 50 acquisitions since 1992. Through these buyouts, management looks to enhance its manufacturing capabilities, operating synergies, distribution network, economies of scale and market advantages.
On the last day of December 2020, management unveiled plans to buy Green Garden Products (Green Garden) for $532 million. Green Garden is a key provider of vegetables, seed starters, herb and flower seed packets, and plant nutrients across North America. Markedly, the acquisition is expected to expand Central Garden & Pet’s portfolio into an attractive adjacent category and reinforce its relationship with important retailers. This deal is expected to conclude in second-quarter fiscal 2021.
Prior to the Green Garden deal announcement, Central Garden & Pet unveiled plans to buy Hopewell Nursery, which is a key live goods grower that caters to retail nurseries, landscape contractors, wholesalers and garden centers in the Northeast. This deal, which follows the addition of Bell Nursery to the company’s portfolio, will strengthen the company’s position in the live goods space with high-quality offerings.
Earlier, the company had acquired C&S Products, which has been complementing its existing wild bird feed business. It has also taken over the remaining 55% stake in Arden Companies. The company also bought Bell Nursery, a leading grower and distributor of live flowers and plants, as well as General Pet Supply, a supplier of pet food and supplies. All these buyouts are fueling this Zacks Rank #3 (Hold) company’s top line, which improved 25% year over year during fourth-quarter fiscal 2020.
Clearly, Central Garden & Pet has been strengthening its position in the pet supplies, and lawn and garden supplies space. Moreover, it has been developing new products, advancing digital capabilities, optimizing supply chain and focusing on marketing activities. Impressively, the California-based firm’s shares have risen 25.7% over the past year versus the industry’s 19.1% rise.
Party City Holdco , also a Zacks Rank #2 stock, delivered an earnings surprise of 121.7% in the last-reported quarter.
Spectrum Brands (SPB - Free Report) has an expected long-term earnings growth rate of 18.3% and currently holds a Zacks Rank #2.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Central Garden & Pet's (CENT) DoMyOwn Buyout to Boost Sales
As online activities have picked up amid the coronavirus crisis, Central Garden & Pet Company (CENT - Free Report) is committed toward accelerating its digital efforts. Encouragingly, the company recently bought DoMyOwn.com (DoMyOwn), which is a fast-growing online retailer of professional-grade control products across the United States. The deal adds best-in-class e-commerce fulfillment platform and digital capabilities to the company’s portfolio as well as fortifies Central Garden & Pet’s position in the control product space. We note that the transaction was completed on Dec 18, 2020, and terms of the deal including purchase price have been kept under wraps.
Founded in Norcross, GA, in 2004, DoMyOwn used to initially focus on selling professional-grade control products online. In 2012, it added turf and ornamental products. Later in 2017, the online company had enhanced its geographical reach with warehouse additions in Utah and expanded into pet and equine products. Its digitally-driven management group and nearly 70 employees helped it become the leading online and wholesale supplier of professional-grade control products for do-it-yourself customers.
Markedly, the latest acquisition fits pretty well with Central Garden & Pet’s ‘Central to Home’ initiative. This strategy is devoted toward catering to consumer needs, reinforcing partnerships, building scale in core categories and adding digital capabilities. With the help of this acquisition, Central Garden & Pet will be able to tap and cater to the rising e-commerce demand of consumers and the retail customers’ omni-channel platforms.
Acquisition Strategy Drives Sales
We note that acquisitions form an important part of Central Garden & Pet’s strategy. The company has expanded its business via more than 50 acquisitions since 1992. Through these buyouts, management looks to enhance its manufacturing capabilities, operating synergies, distribution network, economies of scale and market advantages.
On the last day of December 2020, management unveiled plans to buy Green Garden Products (Green Garden) for $532 million. Green Garden is a key provider of vegetables, seed starters, herb and flower seed packets, and plant nutrients across North America. Markedly, the acquisition is expected to expand Central Garden & Pet’s portfolio into an attractive adjacent category and reinforce its relationship with important retailers. This deal is expected to conclude in second-quarter fiscal 2021.
Prior to the Green Garden deal announcement, Central Garden & Pet unveiled plans to buy Hopewell Nursery, which is a key live goods grower that caters to retail nurseries, landscape contractors, wholesalers and garden centers in the Northeast. This deal, which follows the addition of Bell Nursery to the company’s portfolio, will strengthen the company’s position in the live goods space with high-quality offerings.
Earlier, the company had acquired C&S Products, which has been complementing its existing wild bird feed business. It has also taken over the remaining 55% stake in Arden Companies. The company also bought Bell Nursery, a leading grower and distributor of live flowers and plants, as well as General Pet Supply, a supplier of pet food and supplies. All these buyouts are fueling this Zacks Rank #3 (Hold) company’s top line, which improved 25% year over year during fourth-quarter fiscal 2020.
Clearly, Central Garden & Pet has been strengthening its position in the pet supplies, and lawn and garden supplies space. Moreover, it has been developing new products, advancing digital capabilities, optimizing supply chain and focusing on marketing activities. Impressively, the California-based firm’s shares have risen 25.7% over the past year versus the industry’s 19.1% rise.
Solid Consumer Discretionary Bets
Reynolds Consumer Products REYN has a trailing four-quarter earnings average of 5.7% and a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Party City Holdco , also a Zacks Rank #2 stock, delivered an earnings surprise of 121.7% in the last-reported quarter.
Spectrum Brands (SPB - Free Report) has an expected long-term earnings growth rate of 18.3% and currently holds a Zacks Rank #2.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>